Efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-FU as first-line treatment for patients with metastatic colorectal cancer.
暂无分享,去创建一个
S. Clarke | S. Ackland | A. Sobrero | B. Langer | A. Zurlo | C. G. Girón | S. Young | S. Chiara | R. P. Carrión